The most informative method for assessing tubal patency in subfertile women is laparoscopy-and-dye. This investigation, however, puts a large burden on services and a screening test is needed that identifies a high likelihood of occlusion. In our infertility programme we introduced hysterosalpingo contrast sonography for this purpose, operated entirely by ultrasonographers. A series of audits indicated that this innovation speeded the process of investigation by several weeks and reduced the number of laparoscopy-and-dye procedures by 75%. The negative predictive value was 89% and the positive predictive value was 44%. The main limitation of the method was the long period required for training, in those without extensive experience of vaginal ultrasonography.
INTRODUCTION
The aetiology of subfertility is not always an isolated abnormality. A high proportion of couples referred for subfertility have multiple disorders, the combination of which accounts for their inability to conceive. If a woman is found not to ovulate regularly or if her husband is azoospermic this does not mean that she cannot have damaged fallopian tubes as well. This means that a battery of tests is necessary for all subfertile couples before a decision on the most appropriate therapy. Fallopian tube patency needs to be established in all subfertile women, with the possible exception of those whose partner is severely oligospermic and in whom in-vitro fertilization is planned.
The usual way to establish tubal patency is by means of laparoscopy-and-dye. This has the advantage of being able to detect other pelvic anatomical abnormalities such as ovarian cysts or endometriosis, and so it remains the gold standard for assessment. However, 1 in 6 of all couples in the developed world are referred for investigation of subfertility at some time in their lives and this places an immense burden on surgical services and exposes large numbers of healthy women to the hazards of anaesthesia. What is needed is a screening test to identify those women with a high likelihood of tubal occlusion.
Possible screening programmes include serum antichlamydial antibodies, hysterosalpingography and the newer technique known as hysterosalpingo contrast sonography (HyCoSy). Several groups have compared HyCoSy screening with either hysterosalpingography or laparoscopyl4 and from these studies the sensitivity was in the region of 47-90% and specificity 87-100%. Here we describe the HyCoSy screening programme that our unit has introduced and share some of our experiences.
THE SCREENING PROGRAMME
Our unit introduced HyCoSy screening in October 1996 for all women referred for subfertility who have not been investigated previously. Procedures are performed in the follicular phase of the cycle, up to five on one afternoon each week. Results are nearly always available within four weeks of referral. Procedures are conducted exclusively by our ultrasonographers without medical assistance. Women are offered laparoscopy if one or both fallopian tubes cannot be demonstrated as patent or if additional pelvic disease (such as an ovarian cyst or endometrioma) is seen on baseline vaginal scanning.
The primary intention of introducing screening was to reduce the surgical waiting list and lessen the number of anaesthetics given to women without disease ( Figure 1 ). The assumptions were that about 15% of referrals would have a tubal problem and that HyCoSy would have a positive predictive value of about 50% and a negative predictive value close to 100%. Hence the number of laparoscopies should be reduced by 70% and half of those laparoscoped should have demonstrable tubal discase, but we should miss very few cases of tubal occlusion. We have performed several clinical audits to check on these original assumptions.
HyCoSy with Echovist Echovist is the ultrasound contrast agent used to delineate the fallopian tubes during HyCoSy. It needs to be prepared immediately before use by mixing galactose microparticles in a saturated solution of galactose. The resulting supersaturated solution contains 200 mg per mL and this gives a viscosity a little less than that of other common contrast agents (4 mPa compared with 8.7 mPa for Ultravist). Its action is due to microbubble formation around the microparticles of galactose which remain in suspension. The multiple surfaces of the microbubbles, which are about 3 4um in diameter, reflect ultrasound very efficiently; the gain setting should be turned down to exclude unwanted shadowing from other surfaces. A total of 5 mL is sufficient for most examinations, injected over about five minutes. Patience is necessary to give time for tubes which may be in spasm to relax and allow flow. Doppler or colour doppler can be helpful in some cases but is not essential3.
A full baseline vaginal ultrasound scan should be performed before introducing contrast so as to determine the anatomical landmarks and identify any incidental disease such as ovarian cysts, polycystic ovaries, hydrosalpinges or endometriomata. If there is any doubt about the regularity of the endometrial cavity this is best delineated with a negative contrast agent such as saline, which should be used before Echovist.
Reduction in unnecessary surgery
An audit of surgical activity before and after the introduction of the screening programme showed the Hysteroscopy Lap and dye Laparoscopy Adhesiolysis Reversal Other expected reduction in surgical procedures related to subfertility ( Figure 2 ). The amount of operating time saved was substantial. Our unit serves a population of about 600 000 in East Yorkshire, which generates 300 referrals for subfertility annually. Saved operating time amounted to the equivalent of 100 minor procedures, 100 intermediate procedures and 28 major procedures a year. One unexpected advantage of the system was the ability to proceed with corrective surgery (for example, in those cases with endometriosis) without resorting to a second planned admission. This was made possible not so much by the increase in available operating time as by the higher probability of finding disease at each laparoscopy. Operating lists could therefore be more effectively managed.
False positives and false negatives During the first year of the programme 167 women were screened. This is less than our total referral number because we are a tertiary referral centre and many women had had laparoscopies previously in secondary centres. 28 (17%) women were screen positive and progressed to laparoscopy-15 with suspected unilateral tubal block, 6 with suspected bilateral block and 7 with other disease. The results of the laparoscopic assessment of each fallopian tube were compared with the results predicted by the HyCoSy screen. Only 3 of 27 tubes that were predicted to be patent were found subsequently to be occluded, giving a negative predictive value of 89%. Of the 27 tubes that were predicted to be occluded 15 were subsequently found to be patent, giving a positive predictive value of 44%.
Patient acceptability
The procedure can be uncomfortable, in much the same way as a hysterosalpingogram, but during HyCoSy the patient is not anchored beneath an X-ray machine and it is much easier for her to be shown the contrast medium as it passes through the tubes. Patients like to have this instant result. Also, in our unit the HyCoSy is performed by ultrasonographers who are part of the in-vitro fertilization team. A professional relationship is therefore initiated which can proceed into treatment.
Our observations suggest that the type of discomfort experienced during a HyCoSy can differ from that experienced during a hysterosalpingography. Both procedures can initiate cramping uterine pains during the insertion of the catheter or instillation of contrast, especially if both tubes are occluded, although the severity of pain has been reported as less with HyCoSy. In addition patients can feel distinctly odd and light-headed if a large volume of Echovist is introduced into the peritoneal cavity. There is no associated hypotension or bradycardia and it does not happen with small volumes of Echovist.
Infection
There is always the potential to introduce infection into the upper genital tract when instruments are passed through the cervix. The Royal College of Obstetricians and Gynaecologists now recommends the use of prophylactic antibiotics for all such procedures and HyCoSy is no exception. The procedure should be avoided if there is any suspicion of cervical infection.
The risk of infection is difficult to quantify. The results of several thousand HyCoSy procedures have been published but patients have seldom been formally asked about symptoms in the month after the investigation. The UK multicentre study in 1995 did not identify any case of infection in 98 recruits who were not given prophylactic antibiotics. It seems probable that the risk is less than 1%.
Subsequent pregnancy rates
We have compared pregnancy rates in our unit before and after the introduction of the screening programme. This is obviously a crude audit tool but if we were missing large numbers of women with blocked fallopian tubes we would expect the pregnancy rate for treatments such as ovulation induction to be reduced. Figure 3 shows that the cumulative pregnancy rate increased after the introduction of the screening programme. It seems unlikely, therefore, that we are missing cases of tubal disease that we diagnosed in previous years with laparoscopy.
Training
Formal ultrasonographer training is probably the most critical part of the whole programme. The expertise required to interpret the images seen at HyCoSy is greater than that for either laparoscopy or hysterosalpingography, where the end-points are obvious. Our department runs a national training programme and we have found it particularly difficult to train those who do not have extensive experience of vaginal ultrasound scanning. The learning curve is shallow and estimates of the number of procedures that need to be performed before an individual ultrasonographer can report confidently and reliably lie between 20 and 50. All of the professionals contributing to the fertility service in our area were convinced of the worth of screening, but if some of them had not wished to use the service the major benefits of screening would have been lost.
LIMITATIONS OF THE
HyCoSy will not demonstrate pelvic adhesions which do not result in tubal occlusion, or endometriosis which does not result in cyst formation. The effect of these conditions on fertility is variable and treatment regimens are controversial. In our programme the patients will be classified as having 'unexplained subfertility' and offered invitro fertilization after a suitable interval.
It must also be accepted that a few cases of tubal disease will be missed even though the false-negative rate is low. However, laparoscopy-and-dye is not without misleading results. We have had one case where HyCoSy demonstrated bilateral tubal patency but laparoscopy indicated bilateral occlusion (a false-negative screen) and the patient subsequently conceived without therapy.
Ideally we would wish to assess tubal function, and laparoscopy is not capable of this. It may be the case, however, that low-pressure HyCoSy is a crude indicator of tubal function. We need to follow up our cases where HyCoSy has demonstrated occluded tubes but laparoscopy has demonstrated patent tubes (false positives) to see if spontaneous pregnancy occurs any less frequently than in cases where HyCoSy has demonstrated patent tubes.
